Psychiatry and Neurology, Neurology · New York, NY
NPI
1033196506
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
425 W 59th St, Suite 7c
New York, NY, 10019
Phone (212) 523-8070
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$5.7M
3,141 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Saud A Sadiq prescribed most often to Medicare patients was Baclofen, with 287 prescriptions and refills. In total Saud A Sadiq wrote 3,141 Medicare prescriptions that cost $5.7M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Baclofen Generic | 287 | 602 | 68 | $7,750 |
| Dalfampridine Er Dalfampridine | 221 | 351 | 35 | $185K |
| Gabapentin Generic | 187 | 332 | 42 | $5,101 |
| Clonazepam Generic | 174 | 184 | 26 | $1,259 |
| Avonex (4 Pack) Interferon Beta-1a | 99 | 117 | Under 11 | $1.0M |
| Methenamine Hippurate Generic | 95 | 175 | 20 | $8,304 |
| Modafinil Generic | 90 | 151 | 18 | $6,584 |
| Ropinirole Hcl Generic | 87 | 183 | 13 | $2,346 |
| Myrbetriq Mirabegron | 76 | 116 | 14 | $51K |
| Valacyclovir Valacyclovir Hcl | 71 | 147 | 17 | $4,120 |
| Mycophenolate Mofetil Generic | 71 | 101 | Under 11 | $3,728 |
| Dextrose In Water Dextrose 5 % In Water | 70 | 70 | Under 11 | $401 |
| Pregabalin Generic | 68 | 86 | 11 | $2,307 |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 66 | 66 | Under 11 | $1.0M |
| Tizanidine Hcl Generic | 61 | 90 | Under 11 | $1,581 |
Brand drugs: - claims; generic drugs: 2,424 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Saud A Sadiq were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.